CHRISTY GIBSON: Open Payments
NPI 1164792198 · HUNTINGTON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$453 in 15 payments from 8 companies in 2025. Trend: 2023 $102 · 2024 $419 · 2025 $453
Food & beverage: $453
| Company | Payments | Amount |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc | 1 | $129 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $127 |
| Galderma Laboratories, L.P. | 1 | $65 |
| Celltrion USA Inc. | 2 | $34 |
| Madrigal Pharmaceuticals | 2 | $31 |
| QOL Medical, LLC | 1 | $25 |
| Ardelyx, Inc. | 1 | $24 |
| PFIZER INC. | 1 | $19 |
Products named: IQIRVO, XIFAXAN, VEGZELMA, REZDIFFRA, Sucraid, IBSRELA, VELSIPITY.
Industry payments across WV — which companies pay providers there.
